“Molecular Mechanisms of Disease:
Tissue Homeostasis, Immune Responses, and Cancer”
Late-Breaking Abstract Submission Deadline:
Friday, September 28, 2018, 11:59 PM (Eastern Standard Time)
All participants at PISA 2018 are invited to submit a late-breaking abstract. Completed late-breaking abstracts must be submitted through use of the online abstract submission system no later than Friday, September 28, 2018 at 11:59 PM (Eastern Standard Time). Faxed, emailed or mailed abstracts will not be accepted. Accepted late-breaking abstracts will be published in the PISA 2018 Program book provided to attendees but will NOT be published in The American Journal of Pathology (AJP). First authors of accepted late-breaking abstracts are expected to present a poster. All authors of late-breaking abstracts must adhere to the ASIP 2018 Scientific Integrity Policy.
PRESENTATION FORMAT: All accepted late-breaking abstracts will be presented as a poster.
RULES FOR LATE-BREAKING ABSTRACT SUBMISSION:
- Product advertisements are not appropriate for presentation. ASIP reserves the right to exclude late-breaking abstracts that promote commercial interests inappropriately or are viewed as unethical in content.
- Completed late-breaking abstracts must be submitted online no later than Friday, September 28, 2018 at 11:59 PM (Eastern Standard Time). No changes can be made to abstract content or authors after the submission deadline.
- All late-breaking abstracts must be submitted through use of the online abstract submission system. Faxed, emailed or mailed abstracts will not be accepted.
- Once a late-breaking abstract is accepted, additional authors cannot be added.
- The Presenting (First) Author should be the primary contact.
- Notification of acceptance or rejection of the late-breaking abstract will be e-mailed to the Presenting (First) Author from the ASIP office by Friday, October 5, 2018.
- ASIP reserves the right to withdraw a presentation at any time.
- Accepted late-breaking abstracts will be printed in the Program Book and distributed to meeting attendees only. Late-breaking abstracts also will NOT be published in The American Journal of Pathology (AJP).
- The Presenting (First) Author is required to register and attend PISA 2018 and present the poster at the assigned time on the assigned day. He/she must be available to answer questions. If the Presenting Author is unable to attend PISA 2018 to present the poster, every effort should be made to arrange for one of the other authors to present. ASIP staff (Lmcfadden@asip.org) must be notified of any change in presenters.
- The Presenting Author verifies that all authors agree, and any supervisors have given permission, to the presentation of a scientific poster at PISA 2018 and the inclusion of the late-breaking abstract in the Program Book.
- The Presenting Author is responsible for notifying all other authors of acceptance, rejection, scheduling and any other information provided by ASIP.
- The Presenting Author is responsible for compliance with the ASIP 2018 Scientific Integrity Policy.
- IMPORTANT:A disclosure report of relevant financial relationships is required for each author of a submitted late-breaking abstract. We recommend that the Presenting Author collect disclosure information from each author before beginning the late-breaking abstract submission in order to expedite the online entry process. Each time an author is added during the online submission process, complete contact information and conflict of interest disclosure specific to that author is required.
- By submitting a late-breaking abstract (click “Create New”), the Presenting Author is agreeing to the following:
I have read, understand, and agree to the ASIP Rules for late-breaking abstract submission and for the poster presentation layout and size requirements. I understand that failure to adhere to these rules may result in denial of permission to display the poster, disqualification for an award, and/or forfeiture of future rights to submit abstracts to the PISA conference.
LATE-BREAKING ABSTRACT FORMATTING INSTRUCTIONS
Abstracts that are not submitted properly will receive an administrative reject and will not be reviewed.
- Language: The late-breaking abstract must be written in English.
- Presentation Format: Your late-breaking abstract will be presented as a poster.
- Title: Title must be initial caps throughout. Example: Molecular Mechanisms of Autophagy in Breast Cancer
- Late-breaking abstracts must be 300 words or less (excluding the title, authors, and affiliations).
- Late-breaking abstracts must be submitted properly. The online system is a database with data fields (title, author 1, author 2, author 3, etc.) that are used to generate the printed abstracts. Therefore, pay careful attention to the submission instructions and to the submission process. Ask for technical support (see link at top of submission screens) if you are not sure.
- Abstract Limits:
- Number of Authors: 15
- Abstract Title: 200 characters
- Abstract Content: 300 words
You may include Greek letters and special symbols, e.g. ° (degree sign), ® (registered trademark), etc. However, the system will not accept or preserve tables or figures. Data must be reported in narrative format in the abstract submission.
- The scientific content of the late-breaking abstract should contain new data that have not been published.
- Confirmation: When you finish submitting your late-breaking abstract, you will receive a confirmation screen verifying your submission and assigning a tracking number to your late-breaking abstract. SAVE YOUR TRACKING NUMBER! It will serve as your identification number for corrections, scheduling, and notification and will be required if an application for a travel award is submitted.
- Authors may submit multiple late-breaking abstracts.
- CORRECTIONS: If you must change your late-breaking abstract, log in as a returning user with your email address and password. You will be able to edit your submitted late-breaking abstract(s) until Friday, September 28, 2018. Please click the ID number of the late-breaking abstract you wish to edit. DO NOT CREATE A NEW SUBMISSION.
NOTE: You can edit your completed late-breaking abstract an unlimited number of times until the deadline, for example, to add an author or correct spelling, etc. However, after the deadline, no changes of any kind can be made.
- Poster Size Requirement: The maximum poster size is 4 feet (122cm) high by 6 feet (1.8 meters) wide. ASIP reserves the right to remove posters that exceed the size requirement
- Posters must be attended by the Presenting Author during the assigned time period(s). Award applicants may be required to attend their posters at additional designated time period/s. The poster attendance schedule will also be noted in the online Preliminary Program and in the printed Program Book.
- If the scientific content of the submitted late-breaking abstract has been altered since its submission, a notice that a revised late-breaking abstract has been posted must be included.
PRESENTING (FIRST) AUTHOR RESPONISIBILITIES
The Presenting (First) Author is the individual who submits the late-breaking abstract and is the contact person for all correspondence from ASIP. The Presenting Author:
- verifies that all authors agree to the inclusion of the late-breaking abstract in the Program Book.
- verifies that all authors agree, and any supervisors have given permission, to the presentation of a scientific poster at the annual meeting.
- is responsible for notifying all other authors of acceptance, rejection, scheduling, and distribution of any other
- information provided by ASIP.
- selects a Topic Category (see Topic Category list below).
- collects contact information and conflict of interest disclosure information for each author before initiating late-breaking abstract submission (see Conflict of Interest Policy below)
- is responsible for compliance with the ASIP 2018 Scientific Integrity Policy.
Late-Breaking abstract are NOT eligible for travel awards. However, authors of late-breaking abstracts will be invited to apply for a Poster Award.
TOPIC CATEGORIES (the PISA 2018 Program Committee reserves the right to reassign topic categories after review):
Atherosclerosis and Cardiovascular Disease
Cancer Niches and Developmental Pathway Signaling
Cardiac and Cardiovascular Pathobiology
Cell-Cell Communications and Exosomes
Cell Injury and Repair
Epithelial and Mucosal Pathobiology
Imaging, Immunohistochemistry, and Microscopy
Immunology, Immunity, and Immunotherapy
Neoplasia, Cancer Genomics, and Therapeutics
CONFLICT OF INTEREST POLICY
The American Society for Investigative Pathology (ASIP) has implemented a process where everyone who is in a position to control the content of its scientific conferences must disclose all relevant financial relationships with any commercial interest and any conflicts of interest must be resolved prior to the meeting and available for review by the conference attendees so they may independently judge that the presented work is free from bias. Information will be reviewed by the ASIP Executive Officer; a determination will be made to manage any disclosed conflicts with safeguards against any potential bias. This is not intended to prevent participation unless the conflict of interest is determined to be unresolvable. Refusal to disclose means that you relinquish your ability to participate in PISA 2018.
Circumstances create a conflict of interest when an individual has an opportunity to affect the educational content of the scientific conference about products or services of a commercial interest with which he/she has a financial relationship. The conflict of interest depends on the situation and not on the character or actions of the individual. Financial relationships are those relationships in which the individual or his/her spouse or partner benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (excluding diversified mutual funds), or other financial benefit; these are usually associated with roles such as employment, independent contractor (including contracted research), consulting, speaking and teaching, advisory/review panel or board membership, etc. A relevant financial relationship is one that creates a conflict of interest, in any amount, occurring in the 12 months before the individual assumes a role controlling educational content.